Sigurd F Lax Selected Research

Sigurd F Lax Research Topics

Disease

14	Neoplasms (Cancer) 10/2023 - 05/2008
7	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2002
6	Carcinoma (Carcinomatosis) 10/2023 - 07/2002
4	COVID-19 03/2021 - 01/2020
3	Microsatellite Instability 10/2023 - 10/2002
3	Endometrioid Carcinoma 02/2023 - 03/2004
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2020
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 09/2003
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 02/2023 - 01/2023
2	Neoplasm Metastasis (Metastasis) 08/2022 - 11/2017
2	Endometrial Neoplasms (Endometrial Cancer) 02/2021 - 11/2017
2	Ovarian Neoplasms (Ovarian Cancer) 04/2018 - 01/2018
2	Endometrial Hyperplasia 01/2017 - 03/2004
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023
1	Carcinogenesis 02/2023
1	Vaginal Neoplasms (Cancer, Vaginal) 01/2023
1	Adenocarcinoma 08/2022
1	Uterine Cervical Dysplasia 01/2022
1	Thrombosis (Thrombus) 01/2020
1	Thromboembolism 01/2020
1	Venous Thromboembolism 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Xeroderma Pigmentosum (Kaposi's Disease) 01/2017
1	Adenoma (Adenomas) 01/2017
1	Ductal Carcinoma 05/2008
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2023 - 04/2018
3	Messenger RNA (mRNA)IBA 02/2023 - 01/2018
3	Estrogens (Estrogen)FDA Link 01/2017 - 08/2003
2	RNA (Ribonucleic Acid)IBA 01/2023 - 02/2021
2	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 11/2020
2	Formaldehyde (Formol)FDA Link 01/2022 - 08/2003
2	ParaffinIBA 01/2022 - 08/2003
2	Tamoxifen FDA LinkGeneric 01/2022 - 11/2020
2	Viral RNAIBA 03/2021 - 01/2021
2	Hormones (Hormone)IBA 11/2020 - 10/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2004 - 08/2003
1	Naphazoline (All Clear)FDA LinkGeneric 10/2023
1	SynaptophysinIBA 06/2023
1	ChromograninsIBA 06/2023
1	Inosine Monophosphate (IMP)IBA 02/2023
1	Carrier Proteins (Binding Protein)IBA 02/2023
1	AntibodiesIBA 02/2023
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Gefitinib (Iressa)FDA Link 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	regorafenibIBA 01/2023
1	AZD 6244IBA 01/2023
1	Keratin-17 (Keratin 17)IBA 08/2022
1	CK 17IBA 08/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	Goserelin (Zoladex)FDA Link 11/2020
1	Phenobarbital (Luminal)FDA Link 11/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	Methotrexate (Mexate)FDA LinkGeneric 11/2020
1	AnticoagulantsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 05/2019
1	PlatinumIBA 01/2018
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 11/2017
1	CateninsIBA 01/2017
1	Cyclin EIBA 01/2017
1	pembrolizumabIBA 01/2017
1	Aromatase InhibitorsIBA 05/2008
1	EnzymesIBA 05/2008
1	Aromatase (CYP19)IBA 05/2008
1	Cadherins (E-Cadherin)IBA 03/2004
1	beta CateninIBA 03/2004
1	Steroid Receptors (Steroid Receptor)IBA 08/2003
1	Androgen Receptors (Androgen Receptor)IBA 08/2003
1	Monoclonal AntibodiesIBA 08/2003
1	polyacrylamideIBA 10/2002
1	SteroidsIBA 10/2002
1	Technetium (Technetium 99m)IBA 07/2002

Therapy/Procedure

5	Therapeutics 01/2023 - 10/2002
3	Radiotherapy 01/2023 - 07/2018
2	Drug Therapy (Chemotherapy) 11/2020 - 01/2018
1	Immunotherapy 10/2023
1	Surgical Instruments (Clip) 01/2023
1	Conservative Treatment 01/2022
1	Palliative Care (Palliative Therapy) 02/2021
1	Lymph Node Excision (Lymph Node Dissection) 09/2003
1	Mastectomy (Mammectomy) 10/2002